Author details

Full Name

Pei Lin

Affiliation

ORCID

Career Start Year

1998

Papers

245

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36453104	<i>DUSP22</i> rearrangement is associated with a distinctive immunophenotype but not outcome in patients with systemic ALK-negative anaplastic large cell lymphoma.	Haematologica	2023
36325892	Unique pathologic features and gene expression signatures distinguish blastoid high-grade B-cell lymphoma from B-acute lymphoblastic leukemia/lymphoma.	Haematologica	2023
37820764	The Clinicopathologic Features and Molecular Signatures of Blastoid High-Grade B Cell Lymphoma, Not Otherwise Specified.		2023
37723227	Targeted single-cell proteomic analysis identifies new liquid biopsy biomarkers associated with multiple myeloma.	NPJ Precis Oncol	2023
38070713	Management and Outcomes of Patients with Refractory Solitary Plasmacytoma after Treatment with Definitive Radiation Therapy.		2023
38067393	Cytogenetic Profile in Monoclonal Gammopathy of Undetermined Significance, Smoldering and Symptomatic Multiple Myeloma: A Study of 1087 Patients with Highly Purified Plasma Cells.		2023
37212518	Plasma cell myeloma with RAS/BRAF mutations is frequently associated with a complex karyotype, advanced stage disease, and poorer prognosis.		2023
37090805	Use of gene therapy for optic nerve protection: Current concepts.		2023
36513804	High-grade B-cell lymphoma (HGBL)-NOS is clinicopathologically and genetically more similar to DLBCL/HGBL-DH than DLBCL.		2023
36584716	Classic Hodgkin lymphoma with marked granulomatous reaction: A clinicopathologic study of 20 cases.		2023
36765805	Blastoid B-Cell Neoplasms: Diagnostic Challenges and Solutions.		2023
36646323	Autologous Stem Cell Transplantation for Patients with Multiple Myeloma with Translocation (4;14): The MD Anderson Cancer Center Experience.		2023
37137874	Impact of clonal plasma cells in autografts on outcomes in high-risk multiple myeloma patients.		2023
37311413	Single cell clonotypic and transcriptional evolution of multiple myeloma precursor disease.	Cancer Cell	2023
36617265	Canalization of Phenotypes-When the Transcriptome is Constantly but Weakly Perturbed.		2023
36990279	Clinicopathologic Features of Therapy-Related Myeloid Neoplasms in Patients with Myeloma in the Era of Novel Therapies.	Mod Pathol	2023
35074072	Ibrutinib-rituximab followed by R-HCVAD as frontline treatment for young patients (â¿¤65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trial.	Lancet Oncol	2022
36244464	Lymphoplasmacytic lymphoma with IgG or IgA paraprotein: a study of 29 cases including cases that can mimic plasma cell neoplasms.	Human Pathology	2022
35523847	KRD vs. VRD as induction before autologous hematopoietic progenitor cell transplantation for high-risk multiple myeloma.	Bone Marrow Transplantation	2022
36362214	Characterization of BCMA Expression in Circulating Rare Single Cells of Patients with Plasma Cell Neoplasms.	Int J Mol Sci	2022
36296629	Development of an HPV Genotype Detection Platform Based on Aggregation-Induced Emission (AIE) and Flow-Through Hybridization Technologies.	Molecules	2022
35760800	Osteocyte CIITA aggravates osteolytic bone lesions in myeloma.	Nat Commun	2022
36156384	Flow cytometry immunophenotypic features of pure erythroid leukemia and the distinction from reactive erythroid precursors.	Cytometry Part B - Clinical Cytometry	2022
35690645	Clinicopathologic spectrum of myeloid neoplasms with concurrent myeloproliferative neoplasm driver mutations and SRSF2 mutations.	Mod Pathol	2022
35621632	Enrichment-Free Single-Cell Detection and Morphogenomic Profiling of Myeloma Patient Samples to Delineate Circulating Rare Plasma Cell Clones.	Curr Oncol	2022
36612194	The Impact of Mutation of Myelodysplasia-Related Genes in De Novo Acute Myeloid Leukemia Carrying <i>NPM1</i> Mutation.	Cancers (Basel)	2022
36467806	Diffuse large B-cell lymphoma with phenotype switch, anaplastic features and aberrant T-cell marker expression during disease evolution.	EJHaem	2022
34628481	Small cell/lymphohistiocytic morphology is associated with peripheral blood involvement, CD8 positivity and retained T-cell antigens, but not outcome in adults with ALK+ anaplastic large cell lymphoma.	Mod Pathol	2022
34980213	Induction of mA methylation in adipocyte exosomal LncRNAs mediates myeloma drug resistance.	Journal of Experimental and Clinical Cancer Research	2022
34974290	Newly designed breakapart FISH probe helps to identify cases with true MECOM rearrangement in myeloid malignancies.	Cancer genetics	2022
34898335	Molecular characterization of Novel <i>ATM</i> fusions in chronic lymphocytic leukemia and T-cell prolymphocytic leukemia.	Leuk Lymphoma	2022
34608246	Blastoid high-grade B-cell lymphoma initially presenting in bone marrow: a diagnostic challenge.	Modern Pathology	2022
34717192	MALT lymphoma of the tongue: An unusual site that may present a diagnostic challenge.	Annals of Diagnostic Pathology	2022
34767860	Mantle cell lymphoma with chronic lymphocytic leukemia-like features: a diagnostic mimic and pitfall.	Hum Pathol	2022
34887091	The many faces of plasma cell neoplasms: morphological and immunophenotypical variants of the great imitator.	Pathology	2022
35005838	Evaluation of multiple myeloma measurable residual disease by high sensitivity flow cytometry: An international harmonized approach for data analysis.	Cytometry Part B - Clinical Cytometry	2022
34882210	Acute myeloid leukemia with erythroid and megakaryocytic differentiation associated with Down syndrome.	Blood	2021
35845277	An unusual case of splenic B-cell lymphoma/leukemia.		2021
32273477	rearrangement but not extra copies is an independent prognostic factor in patients with mantle cell lymphoma.	Haematologica	2021
33486754	Gene expression profiling predicts relapse-free and overall survival in newly diagnosed myeloma patients treated with novel therapies.	British Journal of Haematology	2021
33480649	Venetoclax and Decitabine in Pediatric Refractory T-cell Lymphoblastic Lymphoma.	Journal of Pediatric Hematology/Oncology	2021
34150666	Promotion of Bone Lesions Through the Myeloma Integrin Î±6-Mediated Osteolytic Signaling.	Frontiers in Oncology	2021
33306129	Run or Die in the Evolution of New MicroRNAs-Testing the Red Queen Hypothesis on De Novo New Genes.	Molecular Biology and Evolution	2021
32908255	The survival impact of CKS1B gains or amplification is dependent on the background karyotype and TP53 deletion status in patients with myeloma.	Modern Pathology	2021
33216956	Anaplastic lymphoma kinase (ALK)-negative anaplastic large cell lymphoma with MYC rearrangement.	Br J Haematol	2021
33406405	Acetyl-CoA Synthetase 2: A Critical Linkage in Obesity-Induced Tumorigenesis in Myeloma.	Cell Metab	2021
34402058	B-cell lymphoma/leukaemia 11B (BCL11B) expression status helps distinguish early T-cell precursor acute lymphoblastic leukaemia/lymphoma (ETP-ALL/LBL) from other subtypes of T-cell ALL/LBL.	British Journal of Haematology	2021
32946567	Incidental Richter transformation in chronic lymphocytic leukemia patients during temporary interruption of ibrutinib.	Blood Adv	2020
31789408	Molecular and clinical progress in follicular lymphoma lacking the t(14;18) translocation (Review).	International Journal of Oncology	2020
32238878	Clinico-pathologic characteristics and outcomes of the World Health Organization (WHO) provisional entity de novo acute myeloid leukemia with mutated RUNX1.	Mod Pathol	2020